Buprenorphine is offered like a monoproduct or in a merged formulation with naloxone, an opioid antagonist, used to reduce diversion simply because buprenorphine blended with naloxone causes critical withdrawal symptoms when injected. However, naloxone is not orally Energetic, so withdrawal symptoms will not arise when used sublingually as directed